Antipodes Partners awarded

2026 Fund Manager of the Year, Australia

Morningstar Awards 2026 © Morningstar, Inc. All Rights Reserved.

Omicron: The facts that matter for global investors

You can subscribe to our podcast on Apple, Google or Spotify, to be notified as soon as upcoming episodes are published Just as the global economy started hitting its reopening stride, Omicron has seen uncertainty return. First identified in Botswana, Omicron spread to South Africa where the alarm was raised on the 24th November. Since then, the variant has […]

Equity Mates: What is pragmatic value?

In this interview on the Equity Mates Podcast, Alison Savas discusses the fundamentals behind Antipodes’ approach to investing. She also shares insights into two stocks within Antipodes’ global portfolios providing exposure to the decarbonisation supercycle. 

ESG: Driving change and generating alpha

The focus on investing through an ESG lens has intensified. But it’s not as simple as buying stocks with ‘green credentials’, or divesting exposure to carbon or stocks that score poorly on backward-looking metrics.

Value across the market spectrum

A traditional approach to value investing can rely on owning low-multiple stocks expecting mean reversion to generate long-term alpha.

China: Looking beyond the old favourites

When it comes to pragmatic value, China offers a myriad of investment opportunities – attractively priced businesses with strong long-term growth profiles, supported by structural tailwinds.

Challenging the inflation consensus

In this latest episode on the Good Value Podcast, listen to a discussion about the inflation debate, the structural drivers that could lead to higher inflation and how Antipodes is positioning for inflation.

Now available on the ASX: the Antipodes Global SMID Active ETF (ASX:MIDS)

X